Glenmark Pharma may test Rs 650: SP Tulsian

SP Tulsian of sptulsian.com told CNBC-TV18, "If one holds Glenmark Pharma for six months then he/she can look for a price of Rs 650 because the way the stock has been performing, the way they have been delivering the results, their research pipeline, their presence in US, even their Q3 numbers has been very good. The way market was expecting and they have performed much better.”

“Its Q2 had some exception but overall taking a call maybe with a time horizon of six months one can look for a price of Rs 650,” he added.